Watch AVTX. Know when insiders buy.
One email the day a filing lands. Free.
AVTX
Avalo Therapeutics, Inc.
12.26
−0.10 −0.81%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
49
WATCH · insiders 34, shorts 64
Insiders, 90 days
−$395K
net selling · 0 buys, 3 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $657.5MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$100.3MNET CASH $70M52W 11.27 – 22.87SEC XBRL · TTM TO Invalid Date
Insider trading
−$395K
Net, 90 days
0 / 3
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 16 | Sep 18 | Sullivan Christopher Ryan · Chief Financial Officer | Sell | 12,394 | $16.33 | $202K |
| Sep 10 | Sep 11 | Sullivan Christopher Ryan · Chief Financial Officer | Sell | 10,185 | $17.62 | $179K |
| Aug 28 | Sep 1 | Doyle Mittie · Chief Medical Officer | Sell | 679 | $20.00 | $14K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.